Sign in
8-K

Current Report

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-25-005129

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading cns_8k.htm…